The Hematology Team is led by Suzanne Kirby, M.D., Ph. D., and Kali Freeman, M.D. Dr. Kirby is a clinical expert in the treatment of hematologic malignancies including leukemia, multiple myeloma and lymphomas. Dr. Freeman is an expert in the diagnosis of hematologic malignancies. They also work with colleagues at Duke Health to provide world class care for malignant as well as benign hematologic disease processes.
One of the five monthly tumor board conferences is primarily devoted to hematology. The tumor board conferences are conducted by our physician-based teams at Scully-Welsh cancer center and often include input from Duke Health doctors. A tumor board is a meeting where complex patient cases are discussed in significant detail by a multidisciplinary team of doctors. The physicians concentrate on patients with difficult tumors or patients who have previously received treatment and, for various reasons, now need a different treatment plan. The doctor teams also review participation in a clinical trial as an option for each patient at the cancer center in Vero Beach. Doctors from each discipline are involved in this meeting and may include nearly a dozen or more cancer experts. Each patient’s diagnosis is introduced, and the group reviews the patient’s scans, biopsies, lab results, and other records with the goal of coming up with the best treatment plan. The team includes other medical oncologists, radiation oncologists, surgical oncology, radiology, interventional radiology, pathology, patient care navigator, nutritionist, and behavioral health specialist.